Literature DB >> 11562433

Nicotinic acid adenine dinucleotide phosphate enhances quantal neurosecretion at the frog neuromuscular junction: possible action on synaptic vesicles in the releasable pool.

E Brailoiu1, M D Miyamoto, N J Dun.   

Abstract

Inositol 1,4,5-trisphosphate (IP(3)) and cyclic adenosine diphosphate-ribose (cADPR) are second messengers that enhance neurosecretion by inducing Ca(2+) release from smooth endoplasmic reticulum (SER). The putative intracellular messenger, nicotinic acid adenine dinucleotide phosphate (NAADP), releases Ca(2+) from stores that are distinct from SER. Evidence is presented here that NAADP causes a concentration-dependent increase in quantal output that is associated with an increase in probability of transmitter release at the frog neuromuscular junction. This effect is mimicked by A23187, a Ca ionophore that promotes Ca(2+) entry at the plasmalemma. The response to NAADP is potentiated by IP(3) but antagonized by cADPR. Thapsigargin completely blocks IP(3) and cADPR responses and decreases but does not prevent the response to NAADP. We conclude that NAADP, whose receptors are widely distributed in the brain, enhances neurosecretion by releasing Ca(2+) from an internal store near the plasmalemma, possibly from synaptic vesicles in the releasable pool. These data also support the hypothesis of a two-pool model for Ca(2+) oscillations at the presynaptic site.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562433

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide.

Authors:  G Cristina Brailoiu; Tudor I Oprea; Pingwei Zhao; Mary E Abood; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2011-06-30       Impact factor: 5.157

2.  Hippocampal mGluR1-dependent long-term potentiation requires NAADP-mediated acidic store Ca2+ signaling.

Authors:  William J Foster; Henry B C Taylor; Zahid Padamsey; Alexander F Jeans; Antony Galione; Nigel J Emptage
Journal:  Sci Signal       Date:  2018-11-27       Impact factor: 8.192

3.  Calmodulin increases transmitter release by mobilizing quanta at the frog motor nerve terminal.

Authors:  Eugen Brailoiu; Michael D Miyamoto; Nae J Dun
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Metabolism of the novel Ca2+-mobilizing messenger nicotinic acid-adenine dinucleotide phosphate via a 2'-specific Ca2+-dependent phosphatase.

Authors:  Georgina Berridge; Rainer Cramer; Antony Galione; Sandip Patel
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

5.  Sphingosine 1-phosphate enhances spontaneous transmitter release at the frog neuromuscular junction.

Authors:  Eugen Brailoiu; Robin L Cooper; Nae J Dun
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

6.  Susceptibility to Calcium Dysregulation during Brain Aging.

Authors:  Ashok Kumar; Karthik Bodhinathan; Thomas C Foster
Journal:  Front Aging Neurosci       Date:  2009-11-27       Impact factor: 5.750

7.  The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals.

Authors:  E Brailoiu; G C Brailoiu; M D Miyamoto; N J Dun
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

8.  Cyclic ADP-Ribose and NAADP in Vascular Regulation and Diseases.

Authors:  Pin-Lan Li; Yang Zhang; Justine M Abais; Joseph K Ritter; Fan Zhang
Journal:  Messenger (Los Angel)       Date:  2013-06-01

9.  Modulation of spontaneous transmitter release from the frog neuromuscular junction by interacting intracellular Ca(2+) stores: critical role for nicotinic acid-adenine dinucleotide phosphate (NAADP).

Authors:  Eugen Brailoiu; Sandip Patel; Nae J Dun
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

10.  Time sensing by NAADP receptors.

Authors:  Dev Churamani; George D Dickinson; Mathias Ziegler; Sandip Patel
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.